Head to Head Review: Neogen (NEOG) vs. Its Competitors

Neogen (NASDAQ:NEOG) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Neogen to similar companies based on the strength of its dividends, risk, earnings, valuation, profitability, analyst recommendations and institutional ownership.

Volatility and Risk

Neogen has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Comparatively, Neogen’s competitors have a beta of 5.49, suggesting that their average stock price is 449% more volatile than the S&P 500.

Profitability

This table compares Neogen and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Neogen	-6.35%	3.29%	2.06%
Neogen Competitors	-278.23%	-150.07%	-21.87%

Analyst Recommendations

This is a breakdown of recent ratings for Neogen and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1	1	3	0	2.40
Neogen Competitors	4252	10480	18203	824	2.46

Neogen currently has a consensus target price of $12.67, suggesting a potential upside of 7.16%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.63%. Given Neogen’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Neogen has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

96.7% of Neogen shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 0.5% of Neogen shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Neogen and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Neogen	$870.40 million	-$7.90 million	-47.28
Neogen Competitors	$1.88 billion	$139.14 million	10.75

Neogen’s competitors have higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Neogen competitors beat Neogen on 8 of the 13 factors compared.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.